Originally appearing here.
On July 30, 2011, MAPS staff Amy Emerson (Clinical Program Manager) and Linnae Ponté (Executive & Clinical Research Assistant) gave an interesting and informative presentation about the current state of psychedelic research at the 2011 Women’s Visionary Congress. Their presentation addressed the prominent role of women in the field of psychedelic therapy research and explored how MAPS’ balanced, respectful approach to its work makes it especially effective as a non-profit pharmaceutical development organization. The Women’s Visionary Congress (http://visionarycongress.org/) is an annual gathering of visionary women healers, scholars, activists and artists who study consciousness and altered states. The WVC supports the transfer of knowledge among women who apply the insights of their research and spiritual path.